Two Sigma Advisers’s Puma Biotechnology PBYI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$843K Sell
245,700
-1,100
-0.4% -$3.77K ﹤0.01% 1523
2025
Q1
$731K Buy
246,800
+49,900
+25% +$148K ﹤0.01% 1611
2024
Q4
$601K Buy
196,900
+35,900
+22% +$109K ﹤0.01% 1708
2024
Q3
$411K Buy
161,000
+25,600
+19% +$65.3K ﹤0.01% 1783
2024
Q2
$441K Sell
135,400
-119,900
-47% -$391K ﹤0.01% 1932
2024
Q1
$1.35M Sell
255,300
-29,500
-10% -$156K ﹤0.01% 1430
2023
Q4
$1.23M Buy
284,800
+25,000
+10% +$108K ﹤0.01% 1538
2023
Q3
$683K Sell
259,800
-84,800
-25% -$223K ﹤0.01% 1679
2023
Q2
$1.22M Sell
344,600
-36,000
-9% -$127K ﹤0.01% 1454
2023
Q1
$1.18M Buy
380,600
+105,200
+38% +$325K ﹤0.01% 1551
2022
Q4
$1.16M Buy
275,400
+88,800
+48% +$376K ﹤0.01% 1505
2022
Q3
$442K Buy
186,600
+45,600
+32% +$108K ﹤0.01% 1890
2022
Q2
$402K Buy
141,000
+48,800
+53% +$139K ﹤0.01% 2018
2022
Q1
$266K Buy
92,200
+39,200
+74% +$113K ﹤0.01% 2277
2021
Q4
$161K Sell
53,000
-161,200
-75% -$490K ﹤0.01% 2342
2021
Q3
$1.5M Buy
214,200
+70,600
+49% +$495K ﹤0.01% 1404
2021
Q2
$1.32M Buy
143,600
+80,200
+126% +$736K ﹤0.01% 1510
2021
Q1
$616K Buy
+63,400
New +$616K ﹤0.01% 1918
2020
Q3
Sell
-207,300
Closed -$2.16M 2583
2020
Q2
$2.16M Sell
207,300
-20,000
-9% -$209K 0.01% 1168
2020
Q1
$1.92M Sell
227,300
-112,200
-33% -$947K 0.01% 1140
2019
Q4
$2.97M Buy
339,500
+6,400
+2% +$56K 0.01% 1053
2019
Q3
$3.59M Buy
333,100
+120,700
+57% +$1.3M 0.01% 888
2019
Q2
$2.7M Buy
212,400
+204,900
+2,732% +$2.6M 0.01% 1082
2019
Q1
$291K Buy
+7,500
New +$291K ﹤0.01% 1997
2018
Q2
Sell
-79,600
Closed -$5.42M 2461
2018
Q1
$5.42M Buy
79,600
+3,300
+4% +$225K 0.01% 818
2017
Q4
$7.54M Buy
76,300
+49,500
+185% +$4.89M 0.02% 702
2017
Q3
$3.21M Buy
+26,800
New +$3.21M 0.01% 991
2015
Q2
Sell
-7,900
Closed -$1.87M 2024
2015
Q1
$1.87M Sell
7,900
-1,600
-17% -$378K 0.01% 803
2014
Q4
$1.8M Buy
9,500
+4,400
+86% +$833K 0.01% 816
2014
Q3
$1.22M Buy
+5,100
New +$1.22M 0.01% 854